ArticleProceedings of the National Academy of Sciences of the United States of America2021
Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
118 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.Systematic reviews · 2024Pooled it
- Inequality in the distribution of Covid-19 vaccine: a systematic review.International journal for equity in health · 2022Pooled it
- Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model.PloS one · 2022Trial
- Optimal timing for staged vaccination campaigns: Insights from scenario tree-based stochastic optimization.Infectious Disease Modelling · 2027Article
- Optimizing vaccine site locations while considering travel inconvenience and public health outcomes.Health care management science · 2026Article
- Modeling individual self-protective behavior during epidemics.PLoS computational biology · 2026Article
- The impact of risk prioritization in COVID-19 vaccination in Belgium on hospital and intensive care unit admissions.European journal of public health · 2026Article
- A compartmental model of variant coexistence, dynamics and dominance in infectious diseases: Case for SARS-CoV-2 in Abu Dhabi.Infectious Disease Modelling · 2026Article
- COVID-19 transmission dynamics: age-specific patterns and super spreaders in South Korea.BMC public health · 2026Article
- Estimation of undetected asymptomatic infections of COVID-19: a mathematical modeling approach.Scientific reports · 2025Article
- Infectious Disease Surveillance in the Era of Big Data and AI: Opportunities and Pitfalls.Cureus · 2025Review
- Vaccine failure mode determines population-level impact of vaccination campaigns during epidemics.Journal of the Royal Society, Interface · 2025Article
- Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization.PloS one · 2025Article
- Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models.Infectious Disease Modelling · 2024Review
- Novel multi-cluster workflow system to support real-time HPC-enabled epidemic science: Investigating the impact of vaccine acceptance on COVID-19 spread.Journal of parallel and distributed computing · 2024Article
- Incorporating social determinants of health into transmission modeling of COVID-19 vaccine in the US: a scoping review.Lancet regional health. Americas · 2024Article
- Vaccination for communicable endemic diseases: optimal allocation of initial and booster vaccine doses.Journal of mathematical biology · 2024Article
- Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models.medRxiv : the preprint server for health sciences · 2024Article
- Balancing the benefits of vaccination: AnPNAS nexus · 2024Article
- Examining the Influence of Imbalanced Social Contact Matrices in Epidemic Models.American journal of epidemiology · 2024Article
58 more citing papers are in PubMed but not listed here.
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
COVID-19 vaccines have been authorized in multiple countries, and more are under rapid development. Careful design of a vaccine prioritization strategy across sociodemographic groups is a crucial public policy challenge given that 1) vaccine supply will be constrained for the first several months of the vaccination campaign, 2) there are stark differences in transmission and severity of impacts from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across groups, and 3) SARS-CoV-2 differs markedly from previous pandemic viruses. We assess the optimal allocation of a limited vaccine supply in the United States across groups differentiated by age and essential worker status, which constrains opportunities for social distancing. We model transmission dynamics using a compartmental model parameterized to capture current understanding of the epidemiological characteristics of COVID-19, including key sources of group heterogeneity (susceptibility, severity, and contact rates). We investigate three alternative policy objectives (minimizing infections, years of life lost, or deaths) and model a dynamic strategy that evolves with the population epidemiological status. We find that this temporal flexibility contributes substantially to public health goals. Older essential workers are typically targeted first. However, depending on the objective, younger essential workers are prioritized to control spread or seniors to directly control mortality. When the objective is minimizing deaths, relative to an untargeted approach, prioritization averts deaths on a range between 20,000 (when nonpharmaceutical interventions are strong) and 300,000 (when these interventions are weak). We illustrate how optimal prioritization is sensitive to several factors, most notably, vaccine effectiveness and supply, rate of transmission, and the magnitude of initial infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.